APA (7th ed.) Citation

AP, L., EF, W., M, C., K, D. S. M., A, W., AD, C., . . . AP, d. S. V. (2019). Silencing the OCT4-PG1 pseudogene reduces OCT-4 protein levels and changes characteristics of the multidrug resistance phenotype in chronic myeloid leukemia. Molecular biology reports, 46(2), 1873. https://doi.org/10.1007/s11033-019-04639-4

Chicago Style (17th ed.) Citation

AP, Lettnin, Wagner EF, Carrett-Dias M, Dos Santos Machado K, Werhli A, Cañedo AD, Trindade GS, and de Souza Votto AP. "Silencing the OCT4-PG1 Pseudogene Reduces OCT-4 Protein Levels and Changes Characteristics of the Multidrug Resistance Phenotype in Chronic Myeloid Leukemia." Molecular Biology Reports 46, no. 2 (2019): 1873. https://doi.org/10.1007/s11033-019-04639-4.

MLA (9th ed.) Citation

AP, Lettnin, et al. "Silencing the OCT4-PG1 Pseudogene Reduces OCT-4 Protein Levels and Changes Characteristics of the Multidrug Resistance Phenotype in Chronic Myeloid Leukemia." Molecular Biology Reports, vol. 46, no. 2, 2019, p. 1873, https://doi.org/10.1007/s11033-019-04639-4.